From: Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
HC (n = 31) | MCI (n = 12) | AD (n = 13) | Group effect | |
---|---|---|---|---|
Age, years (range) | 75.7 ± 5.6 (65–87) | 77.4 ± 9.3 (63–93) | 78.6 ± 7.8 (64–91) | F(2,53) = 0.85; p = 0.43 |
Sex (% women) | 71% | 33% | 31% | x2 = 8.47; p = 0.007 |
Education, years (range) | 15.8 ± 2.4 (8–20) | 17.7 ± 2.0 (14–20) | 16.0 ± 2.6 (12–20) | F(2,53) = 2.85; p = 0.07 |
DRS | 139.8 ± 1.2 | 131.7 ± 2.0a | 120.7 ± 1.9b,c | F(2,50) = 34.22; p < 0.001 |
FAQ | 0.8 ± 0.8 | 3.0 ± 1.4 | 14.6 ± 1.1b,c | F(2,45) = 49.19; p < 0.001 |
LMI | 15.6 ± 1.0 | 8.7 ± 1.5b | 5.4 ± 1.4b | F(2,49) = 18.31; p < 0.001 |
LMD | 14.2 ± 1.1 | 5.2 ± 1.7b | 1.9 ± 1.6b | F(2,49) = 22.20; p < 0.001 |
CVLT-SFR | 10.4 ± 0.5 | 2.9 ± 0.8b | 1.9 ± 0.8b | F(2,45) = 43.36; p < 0.001 |
CVLT-LFR | 11.1 ± 0.4 | 3.2 ± 0.7b | 1.5 ± 0.7b | F(2,45) = 78.42; p < 0.001 |
CERAD-DR | 7.2 ± 0.4 | 2.8 ± 0.6b | 1.0 ± 0.6b | F(2,48) = 38.82; p < 0.001 |
ANART-VIQ | 118.3 ± 1.4 | 117.4 ± 2.2 | 115.1 ± 2.0 | F(2,46) = 0.85; p = 0.43 |
n = 24 | n = 7 | n = 7 | ||
Aβ40, ng/ml | 15.8 ± 1.2 | 11.5 ± 2.5 | 16.1 ± 2.3 | F(2,32) = 1.21; p = 0.31 |
Aβ42, ng/ml | 3.0 ± 0.2 | 1.5 ± 0.5 | 2.0 ± 0.4 | F(2,32) = 4.58; p = 0.02 |